Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Working hypothesis and aims: 1) To explore the pathophysiology of postoperative troponin
elevations and 2) whether ranolazine, a new anti-ischemic drug that has no effect on blood
pressure or heart rate, prevents postoperative myocardial injury.